Blog Archives

Alternative Fakten bei der Zulassung von Generika?

30. März 2017 – Alternative Fakten scheinen nicht nur in der neueren politischen Landschaft Verbreitung zu finden, wenn es darum geht, eigene Interessen durch Falschangaben durch zu setzen. Basierend auf der folgenden Meldung muss man davon ausgehen, dass alternative Fakten auch bei der Zulassung von Generika versuchsweise zum Zuge kommen,

Read more ›

Tags: , , , , , ,

thasso: zustände

thasso: kurzmitteilungen

thasso post: magazin

View my Flipboard Magazine.

thasso: kategorien

thasso: archive

thasso: einfacher chat

You must be a registered user to participate in this chat.

  • How much sunshine causes melanoma? It's in your genes November 21, 2019
    Australian researchers from QIMR Berghofer Medical Research Institute have shown that 22 different genes help to determine how much sun exposure a person needs to receive before developing melanoma.
  • You can test your embryos for genetic defects, but designer babies aren't here just yet November 21, 2019
    Designer baby, anyone? A New Jersey startup company, Genomic Prediction, might be able to help you.
  • Researchers identify a molecular mechanism involved in Huntington's disease November 21, 2019
    Researchers from the Institute of Neurosciences of the University of Barcelona (UBNeuro) and the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) described a mechanism, the increase of proteinaceous synthesis, which takes part in the degeneration of the type of neurons that are affected in Huntington's disease, a genetic neurodegenerative disease. These results, published in […]
  • New Alzheimer risk gene discovered November 21, 2019
    A new paper in the Journal of Neuropathology & Experimental Neurology finds a gene that may help explain a large part of the genetic risk for developing Alzheimer disease.
  • Team publishes findings on TAF1 syndrome November 21, 2019
    An international, multidisciplinary research team from more than 50 institutions, led by geneticist and psychiatrist Gholson Lyon, MD, Ph.D., of the New York State Office for People With Developmental Disabilities' (OPWDD) Institute for Basic Research in Developmental Disabilities (IBR), today announced publication of findings from its study of the rare disease TAF1 syndrome.
Top